Status:
UNKNOWN
Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid
Lead Sponsor:
Meir Medical Center
Conditions:
SARS-CoV-2
Eligibility:
All Genders
18-45 years
Brief Summary
Patients going through an in vitro fertilization cycle will be asked to participate . Patients will be asked for their COVID-19 exposure : post confirmed disease/post vaccine/not exposed to disease or...
Detailed Description
Patients going through an in vitro fertilization cycle will be asked to participate . Patients will be asked for their COVID-19 exposure : post confirmed disease/post vaccine/not exposed to disease or...
Eligibility Criteria
Inclusion
- Planned egg retrieval procedure (including egg preservation)
- Negative PCR for SARS-Cov-19 in the week before egg retrival
- Informed consent
Exclusion
- Positive PCR for SARS-Cov-19 in the week before egg retrival
- expected retrival of 1-3 eggs
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04822012
Start Date
March 1 2021
End Date
June 1 2021
Last Update
March 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel